SSG
NGNE icon

Summit Securities Group’s Neurogene NGNE Stock Holding History

Summit Securities Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5
Closed -$1K – 390
2015
Q3 		$1K Buy
+5
New +$1.15K ﹤0.01% 332

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Summit Securities Group's NGNE Position: Q4 2015 in Review

Summit Securities Group sold out of Neurogene (NGNE) in Q4 2015, closing a stake of 5 shares — an estimated $1K sold.

Summit Securities Group first reported a position in NGNE in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 39 funds tracked by Wall St. Rank hold NGNE as of Q4 2015.

  • Summit Securities Group reported no remaining Neurogene position as of Q4 2015 after selling out during the quarter.
  • Summit Securities Group sold 5 Neurogene shares in Q4 2015, an estimated $1K.
  • Summit Securities Group first reported a position in Neurogene in Q3 2015 and held it in 1 quarter.
  • Summit Securities Group's Neurogene position peaked at $1K in Q3 2015.
  • 39 funds tracked by Wall St. Rank held Neurogene as of Q4 2015.

Based on Summit Securities Group's 13F filing for Q4 2015, filed 11 Feb 2016.